These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32703698)

  • 41. Potential association between COVID-19 mortality and health-care resource availability.
    Ji Y; Ma Z; Peppelenbosch MP; Pan Q
    Lancet Glob Health; 2020 Apr; 8(4):e480. PubMed ID: 32109372
    [No Abstract]   [Full Text] [Related]  

  • 42. COVID-19 and emergency surgery.
    Hogan A
    Br J Surg; 2020 Jun; 107(7):e180. PubMed ID: 32329524
    [No Abstract]   [Full Text] [Related]  

  • 43. Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The "Gabrin sign".
    Wambier CG; Vaño-Galván S; McCoy J; Gomez-Zubiaur A; Herrera S; Hermosa-Gelbard Á; Moreno-Arrones OM; Jiménez-Gómez N; González-Cantero A; Fonda-Pascual P; Segurado-Miravalles G; Shapiro J; Pérez-García B; Goren A
    J Am Acad Dermatol; 2020 Aug; 83(2):680-682. PubMed ID: 32446821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is neutrophilia associated with mortality in COVID-19 patients? A meta-analysis and meta-regression.
    Shi L; Wang Y; Liang X; Xiao W; Duan G; Yang H; Wang Y
    Int J Lab Hematol; 2020 Dec; 42(6):e244-e247. PubMed ID: 32779881
    [No Abstract]   [Full Text] [Related]  

  • 45. Obesity and COVID-19: a call for action from people living with obesity.
    Le Brocq S; Clare K; Bryant M; Roberts K; Tahrani AA; ; ;
    Lancet Diabetes Endocrinol; 2020 Aug; 8(8):652-654. PubMed ID: 32653052
    [No Abstract]   [Full Text] [Related]  

  • 46. Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies.
    Martín-Moro F; Marquet J; Piris M; Michael BM; Sáez AJ; Corona M; Jiménez C; Astibia B; García I; Rodríguez E; García-Hoz C; Fortún-Abete J; Herrera P; López-Jiménez J
    Br J Haematol; 2020 Jul; 190(1):e16-e20. PubMed ID: 32379921
    [No Abstract]   [Full Text] [Related]  

  • 47. Potentially modifiable factors to reduce severity of COVID-19 in type 2 diabetes.
    Dhurandhar NV; Akheruzzaman M; Hegde V
    Nutr Diabetes; 2020 Aug; 10(1):30. PubMed ID: 32788586
    [No Abstract]   [Full Text] [Related]  

  • 48. COVID-19.
    Jung F
    Clin Hemorheol Microcirc; 2020; 74(4):347-348. PubMed ID: 32333579
    [No Abstract]   [Full Text] [Related]  

  • 49. COVID-19 Disease Severity Risk Factors for Pediatric Patients in Italy.
    Bellino S; Punzo O; Rota MC; Del Manso M; Urdiales AM; Andrianou X; Fabiani M; Boros S; Vescio F; Riccardo F; Bella A; Filia A; Rezza G; Villani A; Pezzotti P;
    Pediatrics; 2020 Oct; 146(4):. PubMed ID: 32665373
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.
    Arentz M; Yim E; Klaff L; Lokhandwala S; Riedo FX; Chong M; Lee M
    JAMA; 2020 Apr; 323(16):1612-1614. PubMed ID: 32191259
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The first Vietnamese case of COVID-19 acquired from China.
    Van Cuong L; Giang HTN; Linh LK; Shah J; Van Sy L; Hung TH; Reda A; Truong LN; Tien DX; Huy NT
    Lancet Infect Dis; 2020 Apr; 20(4):408-409. PubMed ID: 32085849
    [No Abstract]   [Full Text] [Related]  

  • 52. SARS-CoV-2 and COVID-19: How much do we know?
    Wang M; Liao Z
    Acta Virol; 2020; 64(3):288-296. PubMed ID: 32985201
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of "normal" risk to improve understanding of dangers of covid-19.
    Spiegelhalter D
    BMJ; 2020 Sep; 370():m3259. PubMed ID: 32907857
    [No Abstract]   [Full Text] [Related]  

  • 54. COVID-19 response and containment strategies in the US, South Korea, and Iceland: Lessons learned and future directions.
    Sen-Crowe B; McKenney M; Elkbuli A
    Am J Emerg Med; 2020 Jul; 38(7):1537-1539. PubMed ID: 32386807
    [No Abstract]   [Full Text] [Related]  

  • 55. COVID-19 mortality in cancer patients in a Madrid hospital during the first 3 weeks of the epidemic.
    Lara Álvarez MÁ; Rogado Revuelta J; Obispo Portero B; Pangua Méndez C; Serrano Montero G; López Alfonso A
    Med Clin (Barc); 2020 Sep; 155(5):202-204. PubMed ID: 32507536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between ABO blood groups and risk of SARS-CoV-2 pneumonia.
    Li J; Wang X; Chen J; Cai Y; Deng A; Yang M
    Br J Haematol; 2020 Jul; 190(1):24-27. PubMed ID: 32379894
    [No Abstract]   [Full Text] [Related]  

  • 57. Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City.
    Miyashita H; Mikami T; Chopra N; Yamada T; Chernyavsky S; Rizk D; Cruz C
    Ann Oncol; 2020 Aug; 31(8):1088-1089. PubMed ID: 32330541
    [No Abstract]   [Full Text] [Related]  

  • 58. Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience.
    Shah V; Ko Ko T; Zuckerman M; Vidler J; Sharif S; Mehra V; Gandhi S; Kuhnl A; Yallop D; Avenoso D; Rice C; Sanderson R; Sarma A; Marsh J; de Lavallade H; Krishnamurthy P; Patten P; Benjamin R; Potter V; Ceesay MM; Mufti GJ; Norton S; Pagliuca A; Galloway J; Kulasekararaj AG
    Br J Haematol; 2020 Sep; 190(5):e279-e282. PubMed ID: 32526039
    [No Abstract]   [Full Text] [Related]  

  • 59. New clinical experiences and evaluation of clinical and paraclinical features of deceased patients with COVID-19 infection referred to Shahid Mostafa Khomeini Hospital of Ilam.
    Ghaysouri A; Sadeghifard N; Nazari A; Kalvandi G; Feizi J; Qasemi E; Kaffashian MR; Borji M; Kokhazadeh T; Tavan H
    Travel Med Infect Dis; 2020; 37():101657. PubMed ID: 32272197
    [No Abstract]   [Full Text] [Related]  

  • 60. Covid-19 - Navigating the Uncharted.
    Fauci AS; Lane HC; Redfield RR
    N Engl J Med; 2020 Mar; 382(13):1268-1269. PubMed ID: 32109011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.